15-89667816-A-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002666.5(PLIN1):c.772-23T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.974 in 1,546,456 control chromosomes in the GnomAD database, including 736,687 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.95 ( 68524 hom., cov: 34)
Exomes 𝑓: 0.98 ( 668163 hom. )
Consequence
PLIN1
NM_002666.5 intron
NM_002666.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.01
Genes affected
PLIN1 (HGNC:9076): (perilipin 1) The protein encoded by this gene coats lipid storage droplets in adipocytes, thereby protecting them until they can be broken down by hormone-sensitive lipase. The encoded protein is the major cAMP-dependent protein kinase substrate in adipocytes and, when unphosphorylated, may play a role in the inhibition of lipolysis. Alternatively spliced transcript variants varying in the 5' UTR, but encoding the same protein, have been found for this gene. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 15-89667816-A-T is Benign according to our data. Variant chr15-89667816-A-T is described in ClinVar as [Benign]. Clinvar id is 1250333.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.99 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLIN1 | ENST00000300055.10 | c.772-23T>A | intron_variant | Intron 6 of 8 | 1 | NM_002666.5 | ENSP00000300055.5 | |||
PLIN1 | ENST00000430628.2 | c.772-23T>A | intron_variant | Intron 6 of 8 | 5 | ENSP00000402167.2 | ||||
PLIN1 | ENST00000560330.1 | c.-176T>A | upstream_gene_variant | 5 | ENSP00000453426.1 |
Frequencies
GnomAD3 genomes AF: 0.946 AC: 144041AN: 152190Hom.: 68488 Cov.: 34
GnomAD3 genomes
AF:
AC:
144041
AN:
152190
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.923 AC: 139202AN: 150790Hom.: 65011 AF XY: 0.932 AC XY: 74418AN XY: 79884
GnomAD3 exomes
AF:
AC:
139202
AN:
150790
Hom.:
AF XY:
AC XY:
74418
AN XY:
79884
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.977 AC: 1362369AN: 1394148Hom.: 668163 Cov.: 48 AF XY: 0.977 AC XY: 672255AN XY: 687938
GnomAD4 exome
AF:
AC:
1362369
AN:
1394148
Hom.:
Cov.:
48
AF XY:
AC XY:
672255
AN XY:
687938
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.946 AC: 144134AN: 152308Hom.: 68524 Cov.: 34 AF XY: 0.941 AC XY: 70081AN XY: 74466
GnomAD4 genome
AF:
AC:
144134
AN:
152308
Hom.:
Cov.:
34
AF XY:
AC XY:
70081
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2901
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 12, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
PLIN1-related familial partial lipodystrophy Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at